Downstream processing: from extraction and filtration to the biopharmaceutical product

This phase, utilizes the process results from the upstream production. By means of new process models, the biopharmaceutical product quality and yield can be monitored more reliably and, hence, be improved.

For this purpose, real-data acquisition and processing is the central aspect. They are the basis for an extensive, holistic process simulation and can contribute to speed up product approval. The simulation models determine the reference variables of the process and make sure it runs under ideal conditions at all times.